Breton Hill Capital Ltd. Buys Shares of 10,341 HCA Holdings, Inc. (HCA)
Breton Hill Capital Ltd. bought a new position in HCA Holdings, Inc. (NYSE:HCA) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,341 shares of the company’s stock, valued at approximately $823,000.
Several other institutional investors and hedge funds also recently modified their holdings of HCA. Northwestern Mutual Wealth Management Co. increased its holdings in HCA Holdings by 14.0% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after purchasing an additional 143 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its holdings in HCA Holdings by 35.1% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after purchasing an additional 320 shares in the last quarter. Atlantic Trust LLC acquired a new stake in HCA Holdings during the 2nd quarter valued at $118,000. Lee Financial Co acquired a new stake in HCA Holdings during the 2nd quarter valued at $125,000. Finally, Acrospire Investment Management LLC increased its holdings in HCA Holdings by 14.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after purchasing an additional 200 shares in the last quarter. 75.18% of the stock is owned by institutional investors and hedge funds.
HCA Holdings, Inc. (HCA) traded down $0.73 during mid-day trading on Friday, reaching $78.68. The company’s stock had a trading volume of 1,804,600 shares, compared to its average volume of 3,287,103. The company has a current ratio of 1.68, a quick ratio of 1.41 and a debt-to-equity ratio of -6.46. The company has a market capitalization of $28,115.31, a price-to-earnings ratio of 12.05, a PEG ratio of 1.17 and a beta of 0.50. HCA Holdings, Inc. has a 52-week low of $68.02 and a 52-week high of $91.03.
HCA Holdings (NYSE:HCA) last posted its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.21. The firm had revenue of $10.70 billion for the quarter, compared to analyst estimates of $10.70 billion. HCA Holdings had a negative return on equity of 47.16% and a net margin of 6.13%. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.45 earnings per share. sell-side analysts expect that HCA Holdings, Inc. will post 6.55 earnings per share for the current year.
HCA Holdings declared that its board has authorized a stock buyback program on Tuesday, October 31st that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.
In other HCA Holdings news, insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $79.88, for a total transaction of $171,742.00. Following the transaction, the insider now directly owns 12,363 shares in the company, valued at $987,556.44. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Over the last quarter, insiders have sold 6,450 shares of company stock worth $511,163. Corporate insiders own 2.90% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was reported by Watch List News and is the property of of Watch List News. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://www.watchlistnews.com/breton-hill-capital-ltd-buys-shares-of-10341-hca-holdings-inc-hca/1696042.html.
A number of research firms recently weighed in on HCA. Argus dropped their price target on HCA Holdings from $100.00 to $93.00 and set a “buy” rating for the company in a report on Monday, August 14th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $82.00 price target on shares of HCA Holdings in a report on Wednesday, November 1st. Citigroup Inc. lowered their target price on HCA Holdings from $87.00 to $81.00 and set a “neutral” rating for the company in a research note on Monday, November 6th. Jefferies Group LLC lowered their target price on HCA Holdings from $90.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, November 1st. Finally, Zacks Investment Research raised HCA Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, August 8th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and seventeen have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $89.95.
HCA Holdings Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Holdings, Inc. (NYSE:HCA).
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.